@article{1d471470a8f0436180b6beadb59f85a8,
title = "Empiric Carbapenems for Nosocomial Pneumonia: Is Hindsight Clearer in 2020?",
author = "Rhodes, {Nathaniel J.} and Wunderink, {Richard G.}",
note = "Funding Information: FINANCIAL/NONFINANCIAL DISCLOSURES: The authors have reported to CHEST the following: N. J. R. discloses receipt of research funds from the American Association of Colleges of Pharmacy, Hartford Hospital and Paratek; receipt of honoraria from the American Society of Health Systems Pharmacists; and patent: WO2017161296A1 (ANTIBIOTIC-COATED NANOPARTICLES). R. G. W. discloses he has received consulting fees from Merck, Shionogi, Microbiotix and bioMerieux, and is on data safety monitoring boards for Pfizer and Vir.",
year = "2021",
month = mar,
doi = "10.1016/j.chest.2020.11.003",
language = "English (US)",
volume = "159",
pages = "897--899",
journal = "Chest",
issn = "0012-3692",
publisher = "American College of Chest Physicians",
number = "3",
}